LTP 13.0% $1.48 ltr pharma limited

Having Aptar in our corner to assist with FDA approval is...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 583 Posts.
    lightbulb Created with Sketch. 292
    Having Aptar in our corner to assist with FDA approval is priceless ( see link to article). We get the benefit of their extensive experience and nasal delivery system. I understand it was two years in the making to get this collaboration! Well done Lee and team on getting such a valuable partner on board. Speaks volume for what we have with Spontan.

    https://aptar.com/news-events/aptar-nasal-unidose-liquid-system-delivers-fda-approved-neffy-epinephrine-nasal-spray/

 
watchlist Created with Sketch. Add LTP (ASX) to my watchlist
(20min delay)
Last
$1.48
Change
0.170(13.0%)
Mkt cap ! $125.4M
Open High Low Value Volume
$1.36 $1.55 $1.35 $2.366M 1.603M

Buyers (Bids)

No. Vol. Price($)
1 4809 $1.48
 

Sellers (Offers)

Price($) Vol. No.
$1.50 10000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
LTP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.